MAT

Opioid Treatment Programs’ Medicaid Patient Retention Rates

Scientific article

23 January 2026

Abstract Importance Retention on methadone and buprenorphine has been shown to be associated with reduced overdose and death. Opioid treatment programs (OTPs) are the only health care facilities in the US licensed to dispense methadone for...

Travel Time to Methadone Treatment Via Personal Vehicle vs Public Transit

Scientific article

3 February 2026

Abstract Importance The requirement for in-person, often daily, attendance at opioid treatment programs (OTPs) makes travel times a barrier to methadone treatment. Research on methadone accessibility has primarily focused on travel via...

Challenges Treating Drug Abuse and Addiction with Co Occurring Disorders in Nairobi and Kiambu.

Report

13 August 2025

Challenges Treating Drug Abuse and Addiction with Co‑Occurring Disorders in Nairobi and Kiambu. Prepared by: Kelvin Ateko, Mental Health Nurse Setting: Urban outpatient/inpatient mental health and addiction services in Nairob ans Kiambu i...

Pharmacological and Behavioral Treatment of Opioid Use Disorder

Scientific article

1 April 2019

Abstract Objective: Opioid use disorder (OUD) in the United States has surged, with an estimated 2.5 million needing treatment. The aim of this article is to provide a clinical overview of the key pharmacological and behavioral treatments...

Methadone Induction in Primary Care for Opioid Dependence: A Pragmatic Randomized Trial (ANRS Methaville)

Scientific article

13 November 2014

Abstract Objective Methadone coverage is poor in many countries due in part to methadone induction being possible only in specialized care (SC). This multicenter pragmatic trial compared the effectiveness of methadone treatment between two...

Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes

Scientific article

28 July 2022

Abstract Background Virtually delivered healthcare (telehealth, telemedicine) has the potential to reduce gaps in access to opioid agonist therapy (OAT). Barriers to accessing OAT such as lack of transportation, in-person induction...

The influence of poly-drug use patterns on the association between opioid agonist treatment engagement and injecting initiation assistance

Scientific article

19 May 2022

Abstract Background Evidence suggests people who inject drugs (PWID) prescribed opioid agonist treatment (OAT) are less likely to provide injection drug use (IDU) initiation assistance. We investigated the association between OAT engagement...

The Intersection of DEA, Opioids, and MAT

27 April 2022

Online

Wednesday, April 27, 2022 @ 3:00-4:00pm ET (2CT/1MT/12PT)

Description

As a result of the opioid crisis, more and more primary care providers are being asked to treat those suffering from opioid use disorder (OUD) through the use of medication assisted treatment (MAT).

The prevalence and pattern of cannabis use among patients attending a methadone treatment clinic in Nairobi, Kenya

Scientific article

15 February 2022

Abstract Background Cannabis use during methadone treatment may negatively impact treatment outcomes. The aim of this study was to determine the prevalence and pattern of cannabis use among patients attending a methadone treatment clinic in...